War on Skin Cancer Scientific Symposium

An OHSU doctor examines the skin on the face and throat of a male patient.

Continuing Medical Education

Saturday, May 19, 2018, 8:00 a.m. - 1:00 p.m.

Collaborative Life Sciences Building
Portland, OR

This one-day course is designed for general practitioners, dermatologists, cancer care providers and researchers. OHSU Knight Cancer Institute physicians and expert guest speakers, including keynote speaker, Dr. Jedd Wolchok from Memorial Sloan Kettering Cancer Center in New York, will provide an overview of the latest advances in the prevention, risk and genetics and local and systemic treatment of melanoma.

Space is limited, so register soon!


The symposium is part of the PDX Skincare Festival, an event where healthcare and skincare unite. Community members are invited to a variety of events on the same day.

At the conclusion of the course, participants will be able to:
  1. Describe the immunologic basis of melanoma immunotherapy.
  2. Describe common immune adverse events and how to treat them.
  3. Discuss the role of molecular aberrations in melanoma and how they are used clinically.
  4. Discuss the pros and cons of regional therapy options for melanoma.
  5. Describe treatment options for uveal melanoma.
  6. Describe treatment options for melanoma brain metastases.
  7. Describe the epidemiology of melanoma and how to best prevent melanoma.
  8. Discuss hereditary melanoma and who should be referred for genetic testing.
  9. Describe which patients are appropriate for Mohs surgery for melanoma.

Course is free for all medical professionals and is designated for a maximum of 5.25 AMA PRA Category 1 Credits™. For more information, please call 503-494-0433 or email .


Saturday, May 19, 2018

8:00 a.m.     Introductory remarks, Oliver Wisco, D.O.

8:10 a.m.     Keynote: Evolution of Adjuvant Therapy, John Kirkwood, M.D.

8:50 a.m.     Q&A Session

9:00 a.m.     Melanoma, Risk and the ABCDEs &Ugly Duckling Sign, Ryan Petering, M.D.

9:15 a.m.     Non-Melanoma Skin Cancer and Common Benign Lesions, Justin Leitenberger, M.D.

9:30 a.m.     Dermoscopy 101, Debbie Miller, M.D.

9:45 a.m.     Q&A Session

10:00 a.m.   Biopsy Basics and Surgery for Localized Disease, Anna Bar, M.D.

10:15 a.m.   Imaging for Melanoma, Nadine Mallak, M.D.

10:30 a.m.   Surgery for Advanced Melanoma, John Vetto, M.D.

10:45 a.m.   Q&A Session

11:00 a.m.   Fundamentals of Medical Therapy for Advanced Disease, Matthew Taylor, M.D.

11:15 a.m.   Current Research in treatment of Melanoma at Providence, Brendan Curti, M.D.

11:30 a.m.   Concepts of Radiation Oncology for Melanoma, Reid Thompson, M.D.

11:45 a.m.   Q&A Session

12:00 p.m.   Early Detection Research, Raj Kulkarni, M.D., Ph.D.

12:15 p.m.   Research on Melanoma Chemoprevention, Pam Cassidy, Ph.D.

12:30 p.m.   The War on Melanoma –Update, Sancy Leachman, M.D., Ph.D.

12:45 p.m.   Q&A Session and Closing Remarks

1:00 p.m.     Adjourn


Oliver Wisco, D.O.

John Kirkwood, M.D.
Dr. Kirkwood is a consultant for Amgen, Array Biopharma, BMS, Merck, Novartis, Roche, and Immunocore, LLD. He receives consulting fees for his activities.

Ryan Petering, M.D.

Justin Leitenberger, M.D.

Debbie Miller, M.D.

Anna Bar, M.D.

Nadine Mallak, M.D.

John Vetto, M.D.
Dr. Vetto is a speaker and consultant for Castle Biosciences (for honoraria fees) and his spouse works for Genentech (salary).

Matthew Taylor, M.D.
Dr. Taylor is a speaker for Eisai Inc. and Bristol Myers Squibb and receives honorarium. He is also a consultant for Trillium Pharma for which he receives Honorarium. He is a consultant for Blue Print Medicine and Loxo Oncology for which he receives honoraria.

Brandon Curti, M.D.
Dr. Curti Is a speaker for BMS and Prometheus (honoraria), is a consultant for Eisai and Alligator Bioscience (consulting fees), and is an investigator for Prometheus, Viralytics, Galectin Therapeutics, MedImmune and BMS (grant support).

Reid Thompson, M.D.

Pamela Cassidy, Ph.D.

Raj Kulkarni, M.D., Ph.D.

Sancy Leachman, M.D.

Program Planning Committee

Sancy Leachman, M.D., Ph.D.

Oliver Wisco, D.O.

John Vetto, M.D.
Dr. Vetto is a speaker and consultant for Castle Biosciences (for honoraria fees) and his spouse works for Genentech (salary).

Faculty Disclosure Information

In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to  disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below. 

In addition, the planners and instructors listed have agreed that all recommendations involving clinical medicine will be based on evidence that is generally accepted within the profession as adequate justification for their indications and contraindications in the care of patients; that all scientific research used in support or justification of a patient care recommendation will conform to the generally accepted standards of experimental design, data collection and analysis; and that material to be presented will be made available for advance peer review if requested.


Credit Statement


Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


OHSU School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration and Contact


Registration includes lunch on Saturday, May 19 and all course materials. Early registration is encouraged, as enrollment is limited.


For more information, please call 503-494-0433 or email .

Request reasonable accommodation for this event at 503-494-2834 or .